Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Br J Clin Psychol. 2012 Sep;51(3):239-60. doi: 10.1111/j.2044-8260.2011.02024.x. Epub 2011 Sep 9.
Mindfulness- and acceptance-based interventions (MABIs) are receiving increasing attention in the treatment of mental disorders. These interventions might be beneficial for patients with anxiety disorders, but no prior reviews have comprehensively investigated the effects of this family of interventions on clinical samples. The aim of this study was to review and synthesize extant research on MABIs for patients with diagnoses of anxiety disorders.
We conducted a systematic search of relevant databases according to pre-defined criteria. Studies were eligible for inclusion if they employed MABIs for patients diagnosed with anxiety disorders.
Nineteen eligible studies were found. Meta-analysis of within-group pre- to post-treatment effects yielded overall Hedges'g effect sizes of 1.08 for anxiety symptoms and 0.85 for depression symptoms. For controlled studies, overall between-group Hedges'g was 0.83 for anxiety symptoms and 0.72 for depression symptoms. Moderator analyses examined whether intervention type, design, treatment dosage, or patient sample was associated with systematic variation in effect sizes. No significant moderating effects were found on the variables examined, apart from an observed superiority in effect size for clinical trials on samples of patients with mixed anxiety disorders. However, differential effect sizes indicated benefits of adding specific psychotherapeutic content to mindfulness training, as well as an advantage of individual over group treatment.
MABIs are associated with robust and substantial reductions in symptoms of anxiety and comorbid depressive symptoms. More research is needed to determine the efficacy of MABIs relative to current treatments of choice, and to clarify the contribution of processes of mindfulness and acceptance to observed outcome.
基于正念和接纳的干预措施(MABIs)在治疗精神障碍方面受到越来越多的关注。这些干预措施可能对焦虑障碍患者有益,但以前没有综述全面调查过这一干预措施对临床样本的效果。本研究旨在综述和综合现有的 MABIs 治疗焦虑障碍患者的研究。
我们根据预先确定的标准对相关数据库进行了系统搜索。如果研究采用 MABIs 治疗被诊断为焦虑障碍的患者,则符合纳入标准。
共发现 19 项符合条件的研究。对组内治疗前后效应的荟萃分析得出,焦虑症状的总体 Hedges'g 效应大小为 1.08,抑郁症状的总体 Hedges'g 效应大小为 0.85。对于对照研究,焦虑症状的总体组间 Hedges'g 为 0.83,抑郁症状的总体组间 Hedges'g 为 0.72。对干预类型、设计、治疗剂量或患者样本是否与效应大小的系统变化相关进行了调节分析。除了在混合焦虑障碍患者样本的临床试验中观察到的效应大小优势外,在检查的变量上没有发现显著的调节效应。然而,差异效应大小表明,将特定的心理治疗内容添加到正念训练中以及将个体治疗改为小组治疗具有优势。
MABIs 与焦虑症状和共病抑郁症状的显著和实质性减少相关。需要进一步的研究来确定 MABIs 相对于当前首选治疗方法的疗效,并阐明正念和接纳过程对观察到的结果的贡献。